I urgently need the Indian version of Evimos.

Everolimus is mainly used to prevent rejection after kidney transplantation and heart transplantation. Its mechanism mainly includes immunosuppression, anti-tumor, anti-virus and vascular protection. It is usually used in combination with other immunosuppressants (such as cyclosporine) to reduce toxicity. Compared with sirolimus, the pharmacokinetics of everolimus is superior. Everolimus was first developed by Novartis, Switzerland, and there are two kinds of tablets and dispersible tablets. The trade name Certican was first listed in Sweden in 2003 and occupied the European market in 2006. You can ask the newly opened specialty pharmacy in Hong Kong. Just click on the internet and you can ask without leaving home.